BSX
HealthcareBoston Scientific Corporation
$68.91+0.35 (+0.51%)
Prev Close
$68.55
Open
$68.96
High
$69.59
Low
$68.41
Volume
8.13M
Market Cap
$101.72B
P/E
35.52
Div Yield
—
Over the past 12 months, insider activity at Boston Scientific Corporation (BSX) has been exclusively selling, with 0 insider purchases totaling $0.00 and 42 insider sales totaling $141.76M. The most recent insider transaction was by Brown Vance R (EVP, GC and Corp. Secretary), who sold $1.09M worth of shares on Feb 13, 2026. Boston Scientific Corporation operates in the Healthcare sector, within the Medical - Devices industry, with a market cap of $101.72B.
Buys (12M)
0
$0.00
Sells (12M)
42
$141.76M
Net Activity
Net Seller
$141.76M
Active Insiders
12
last 12 mo
BSX Price Chart
BSX Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 13, 2026↗ | Brown Vance R | EVP, GC and Corp. Secretary | Sell | 14,577 | $74.73 | $1.09M | 0 |
| Feb 13, 2026↗ | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | Sell | 27,914 | $74.73 | $2.09M | 0 |
| Feb 13, 2026↗ | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | Sell | 36,900 | $74.73 | $2.76M | 0 |
| Feb 13, 2026↗ | Mahoney Michael F | Chairman, President & CEO | Sell | 147,954 | $74.73 | $11.06M | 0 |
| Feb 13, 2026↗ | Monson Jonathan | EVP and CFO | Sell | 1,698 | $74.73 | $126.9K | 0 |
| Feb 13, 2026↗ | O'Connor Padraig Andrew | EVP, Global Operations | Sell | 987 | $74.73 | $73.8K | 0 |
| Feb 13, 2026↗ | O'Sullivan Miriam | SVP, Chief HR Officer | Sell | 820 | $74.73 | $61.3K | 0 |
| Feb 13, 2026↗ | Woodworth Emily | SVP, Global Controller and CAO | Sell | 1,269 | $74.73 | $94.8K | 0 |
| Feb 12, 2026↗ | Brown Vance R | EVP, GC and Corp. Secretary | Sell | 488 | $74.12 | $36.2K | 0 |
| Feb 12, 2026↗ | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | Sell | 1,302 | $74.12 | $96.5K | 0 |
| Feb 12, 2026↗ | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | Sell | 1,612 | $74.12 | $119.5K | 0 |
| Feb 12, 2026↗ | Mahoney Michael F | Chairman, President & CEO | Sell | 6,626 | $74.12 | $491.1K | 0 |
| Feb 12, 2026↗ | Monson Jonathan | EVP and CFO | Sell | 573 | $74.12 | $42.5K | 0 |
| Feb 12, 2026↗ | O'Connor Padraig Andrew | EVP, Global Operations | Sell | 457 | $74.12 | $33.9K | 0 |
| Feb 12, 2026↗ | O'Sullivan Miriam | SVP, Chief HR Officer | Sell | 338 | $74.12 | $25.1K | 0 |
| Feb 12, 2026↗ | Woodworth Emily | SVP, Global Controller and CAO | Sell | 242 | $74.12 | $17.9K | 0 |
| Feb 3, 2026↗ | Mahoney Michael F | director, officer: Chairman, President & CEO | Sell | 160,901 | $93.49 | $15.04M | 1,571,440 |
| Feb 2, 2026↗ | Mahoney Michael F | Chairman, President & CEO | Sell | 160,901 | $93.49 | $15.04M | 0 |
| Dec 1, 2025↗ | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | Sell | 17,313 | $101.55 | $1.76M | 0 |
| Nov 6, 2025↗ | Zane Ellen M | Director | Sell | 12,891 | $98.28 | $1.27M | 0 |
| Nov 3, 2025↗ | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | Sell | 50,000 | $99.47 | $4.97M | 0 |
| Oct 28, 2025↗ | Zane Ellen M | Director | Sell | 12,891 | $101.38 | $1.31M | 0 |
| Oct 1, 2025↗ | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | Sell | 50,000 | $98.47 | $4.92M | 0 |
| Sep 2, 2025↗ | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | Sell | 50,000 | $105.43 | $5.27M | 0 |
| Aug 4, 2025↗ | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | Sell | 17,313 | $104.63 | $1.81M | 0 |
| Aug 4, 2025↗ | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | Sell | 50,000 | $104.63 | $5.23M | 0 |
| Aug 4, 2025↗ | Monson Jonathan | EVP and CFO | Sell | 528 | $105.41 | $55.7K | 0 |
| Jul 29, 2025↗ | FUJIMORI YOSHIAKI | Director | Sell | 2,901 | $106.99 | $310.4K | 0 |
| Jul 28, 2025↗ | LUDWIG EDWARD J | Director | Sell | 4,000 | $106.03 | $424.1K | 0 |
| Jul 2, 2025↗ | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | Sell | 50,000 | $106.97 | $5.35M | 0 |
| Jul 1, 2025↗ | Brown Vance R | SVP, GC and Corp. Secretary | Sell | 1,952 | $104.78 | $204.5K | 0 |
| Jun 4, 2025↗ | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | Sell | 56,372 | $102.88 | $5.80M | 0 |
| Jun 3, 2025↗ | Mahoney Michael F | Chairman, President & CEO | Sell | 164,443 | $103.69 | $17.05M | 0 |
| May 29, 2025↗ | LUDWIG EDWARD J | Director | Sell | 4,000 | $104.59 | $418.4K | 0 |
| May 22, 2025↗ | Brown Vance R | SVP, GC and Corp. Secretary | Sell | 4,826 | $106.42 | $513.6K | 0 |
| May 6, 2025↗ | Sorenson John Bradley | EVP, Global Operations | Sell | 6,490 | $104.66 | $679.2K | 0 |
| May 5, 2025↗ | Mahoney Michael F | Chairman, President & CEO | Sell | 164,443 | $102.48 | $16.85M | 0 |
| May 2, 2025↗ | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | Sell | 1,017 | $104.93 | $106.7K | 0 |
| May 1, 2025↗ | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | Sell | 17,314 | $102.05 | $1.77M | 0 |
| Apr 22, 2025↗ | Brown Vance R | SVP, GC and Corp. Secretary | Sell | 4,826 | $95.09 | $458.9K | 0 |
| Apr 1, 2025↗ | Mahoney Michael F | Chairman, President & CEO | Sell | 164,442 | $100.01 | $16.45M | 0 |
| Mar 24, 2025↗ | Brown Vance R | SVP, GC and Corp. Secretary | Sell | 4,826 | $100.85 | $486.7K | 0 |
| Mar 5, 2025↗ | Woodworth Emily | SVP, Global Controller and CAO | Sell | 7,631 | $104.95 | $800.9K | 0 |
| Feb 28, 2025↗ | Woodworth Emily | SVP, Global Controller and CAO | Sell | 10,242 | $101.22 | $1.04M | 0 |
| Feb 25, 2025↗ | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | Sell | 7,363 | $104.16 | $766.9K | 0 |
| Feb 24, 2025↗ | Zane Ellen M | Director | Sell | 13,586 | $104.23 | $1.42M | 0 |
| Feb 21, 2025↗ | Brown Vance R | SVP, GC and Corp. Secretary | Sell | 4,826 | $104.64 | $505.0K | 0 |
| Feb 19, 2025↗ | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | Sell | 1,510 | $105.35 | $159.1K | 0 |
| Feb 19, 2025↗ | Sorenson John Bradley | EVP, Global Operations | Sell | 5,960 | $104.84 | $624.9K | 0 |
| Feb 18, 2025↗ | Brennan Daniel J. | EVP and CFO | Sell | 84,863 | $105.10 | $8.92M | 0 |
Showing 1–50 of 435
1 / 9
...
BSX Insider Buying Activity
The following table shows recent insider purchases of Boston Scientific Corporation (BSX) stock reported via SEC Form 4 filings.
No insider buying activity found for BSX in the last 12 months.
BSX Insider Selling Activity
The following table shows recent insider sales of Boston Scientific Corporation (BSX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 13, 2026↗ | Brown Vance R | EVP, GC and Corp. Secretary | Sell | 14,577 | $74.73 | $1.09M | 0 |
| Feb 13, 2026↗ | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | Sell | 27,914 | $74.73 | $2.09M | 0 |
| Feb 13, 2026↗ | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | Sell | 36,900 | $74.73 | $2.76M | 0 |
| Feb 13, 2026↗ | Mahoney Michael F | Chairman, President & CEO | Sell | 147,954 | $74.73 | $11.06M | 0 |
| Feb 13, 2026↗ | Monson Jonathan | EVP and CFO | Sell | 1,698 | $74.73 | $126.9K | 0 |
| Feb 13, 2026↗ | O'Connor Padraig Andrew | EVP, Global Operations | Sell | 987 | $74.73 | $73.8K | 0 |
| Feb 13, 2026↗ | O'Sullivan Miriam | SVP, Chief HR Officer | Sell | 820 | $74.73 | $61.3K | 0 |
| Feb 13, 2026↗ | Woodworth Emily | SVP, Global Controller and CAO | Sell | 1,269 | $74.73 | $94.8K | 0 |
| Feb 12, 2026↗ | Brown Vance R | EVP, GC and Corp. Secretary | Sell | 488 | $74.12 | $36.2K | 0 |
| Feb 12, 2026↗ | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | Sell | 1,302 | $74.12 | $96.5K | 0 |
| Feb 12, 2026↗ | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | Sell | 1,612 | $74.12 | $119.5K | 0 |
| Feb 12, 2026↗ | Mahoney Michael F | Chairman, President & CEO | Sell | 6,626 | $74.12 | $491.1K | 0 |
| Feb 12, 2026↗ | Monson Jonathan | EVP and CFO | Sell | 573 | $74.12 | $42.5K | 0 |
| Feb 12, 2026↗ | O'Connor Padraig Andrew | EVP, Global Operations | Sell | 457 | $74.12 | $33.9K | 0 |
| Feb 12, 2026↗ | O'Sullivan Miriam | SVP, Chief HR Officer | Sell | 338 | $74.12 | $25.1K | 0 |
| Feb 12, 2026↗ | Woodworth Emily | SVP, Global Controller and CAO | Sell | 242 | $74.12 | $17.9K | 0 |
| Feb 3, 2026↗ | Mahoney Michael F | director, officer: Chairman, President & CEO | Sell | 160,901 | $93.49 | $15.04M | 1,571,440 |
| Feb 2, 2026↗ | Mahoney Michael F | Chairman, President & CEO | Sell | 160,901 | $93.49 | $15.04M | 0 |
| Dec 1, 2025↗ | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | Sell | 17,313 | $101.55 | $1.76M | 0 |
| Nov 6, 2025↗ | Zane Ellen M | Director | Sell | 12,891 | $98.28 | $1.27M | 0 |
| Nov 3, 2025↗ | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | Sell | 50,000 | $99.47 | $4.97M | 0 |
| Oct 28, 2025↗ | Zane Ellen M | Director | Sell | 12,891 | $101.38 | $1.31M | 0 |
| Oct 1, 2025↗ | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | Sell | 50,000 | $98.47 | $4.92M | 0 |
| Sep 2, 2025↗ | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | Sell | 50,000 | $105.43 | $5.27M | 0 |
| Aug 4, 2025↗ | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | Sell | 17,313 | $104.63 | $1.81M | 0 |
| Aug 4, 2025↗ | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | Sell | 50,000 | $104.63 | $5.23M | 0 |
| Aug 4, 2025↗ | Monson Jonathan | EVP and CFO | Sell | 528 | $105.41 | $55.7K | 0 |
| Jul 29, 2025↗ | FUJIMORI YOSHIAKI | Director | Sell | 2,901 | $106.99 | $310.4K | 0 |
| Jul 28, 2025↗ | LUDWIG EDWARD J | Director | Sell | 4,000 | $106.03 | $424.1K | 0 |
| Jul 2, 2025↗ | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | Sell | 50,000 | $106.97 | $5.35M | 0 |
| Jul 1, 2025↗ | Brown Vance R | SVP, GC and Corp. Secretary | Sell | 1,952 | $104.78 | $204.5K | 0 |
| Jun 4, 2025↗ | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | Sell | 56,372 | $102.88 | $5.80M | 0 |
| Jun 3, 2025↗ | Mahoney Michael F | Chairman, President & CEO | Sell | 164,443 | $103.69 | $17.05M | 0 |
| May 29, 2025↗ | LUDWIG EDWARD J | Director | Sell | 4,000 | $104.59 | $418.4K | 0 |
| May 22, 2025↗ | Brown Vance R | SVP, GC and Corp. Secretary | Sell | 4,826 | $106.42 | $513.6K | 0 |
| May 6, 2025↗ | Sorenson John Bradley | EVP, Global Operations | Sell | 6,490 | $104.66 | $679.2K | 0 |
| May 5, 2025↗ | Mahoney Michael F | Chairman, President & CEO | Sell | 164,443 | $102.48 | $16.85M | 0 |
| May 2, 2025↗ | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | Sell | 1,017 | $104.93 | $106.7K | 0 |
| May 1, 2025↗ | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | Sell | 17,314 | $102.05 | $1.77M | 0 |
| Apr 22, 2025↗ | Brown Vance R | SVP, GC and Corp. Secretary | Sell | 4,826 | $95.09 | $458.9K | 0 |
| Apr 1, 2025↗ | Mahoney Michael F | Chairman, President & CEO | Sell | 164,442 | $100.01 | $16.45M | 0 |
| Mar 24, 2025↗ | Brown Vance R | SVP, GC and Corp. Secretary | Sell | 4,826 | $100.85 | $486.7K | 0 |
| Mar 5, 2025↗ | Woodworth Emily | SVP, Global Controller and CAO | Sell | 7,631 | $104.95 | $800.9K | 0 |
| Feb 28, 2025↗ | Woodworth Emily | SVP, Global Controller and CAO | Sell | 10,242 | $101.22 | $1.04M | 0 |
| Feb 25, 2025↗ | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | Sell | 7,363 | $104.16 | $766.9K | 0 |
| Feb 24, 2025↗ | Zane Ellen M | Director | Sell | 13,586 | $104.23 | $1.42M | 0 |
| Feb 21, 2025↗ | Brown Vance R | SVP, GC and Corp. Secretary | Sell | 4,826 | $104.64 | $505.0K | 0 |
| Feb 19, 2025↗ | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | Sell | 1,510 | $105.35 | $159.1K | 0 |
| Feb 19, 2025↗ | Sorenson John Bradley | EVP, Global Operations | Sell | 5,960 | $104.84 | $624.9K | 0 |
| Feb 18, 2025↗ | Brennan Daniel J. | EVP and CFO | Sell | 84,863 | $105.10 | $8.92M | 0 |
BSX Insiders
Fitzgerald Joseph Michael
EVP & Group Pres, Cardiology
Bought $4.5KSold $69.60M
42 tradesLast: Feb 16, 2026
Similar Stocks to BSX
ABT
Abbott Laboratories
$108.01-0.12%
$187.91B
SYK
Stryker Corporation
$336.96-0.07%
$129.05B
EW
Edwards Lifesciences Corporation
$81.76-3.37%
$49.14B
BRKRP
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A
$273.67-3.21%
$47.35B
DXCM
DexCom, Inc.
$64.51-1.15%
$25.45B
ZBH
Zimmer Biomet Holdings, Inc.
$93.20+0.77%
$18.47B
PODD
Insulet Corporation
$219.84-6.34%
$15.48B
PEN
Penumbra, Inc.
$336.18+0.21%
$13.19B